Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
57 hedge funds and large institutions have $180M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 11 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.41% less ownership
Funds ownership: 80.84% → 80.43% (-0.41%)
12% less funds holding
Funds holding: 65 → 57 (-8)
24% less capital inflows, than outflows
Capital inflows: $3.63M | Capital outflows: $4.79M
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acuta Capital Partners
Redwood City,
California
|
+$1.21M |
| 2 |
First Light Asset Management
Edina,
Minnesota
|
+$472K |
| 3 |
Polar Capital
London,
United Kingdom
|
+$323K |
| 4 |
Renaissance Technologies
New York
|
+$285K |
| 5 |
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$222K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$1.14M |
| 2 |
Granite Investment Partners
El Segundo,
California
|
-$984K |
| 3 |
Deerfield Management
New York
|
-$565K |
| 4 |
Casdin Capital
New York
|
-$564K |
| 5 |
Morgan Stanley
New York
|
-$321K |
OXFD Hedge Fund Activity: Q1 2016 in Review
57 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2016, worth a combined $180M — down 14% from $210M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of OXFD and 3 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 21 added.
The largest buyer was Acuta Capital Partners, adding an estimated $1.21M. The largest seller was Tiverton Asset Management, cutting an estimated $1.14M.
- 57 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2016, down from 65 in Q4 2015.
- Funds reported $180M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2016, down 14% quarter-over-quarter.
- 3 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2016 and 11 closed out, a net change of -8 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2016 was Acuta Capital Partners, an estimated $1.21M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2016 was Tiverton Asset Management, an estimated $1.14M sold.
Based on aggregated 13F filings for Q1 2016.